Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Aflibercept for Diabetic Retinopathy
Recruiting3 awardsPhase 4
West Columbia, South Carolina
This trial will assess the severity of diabetic retinopathy, over 112 weeks, in subjects who completed a previous 2-year trial and were treated in a clinical setting.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.